Pharma Global


Pharma.Global was founded in Russia in 2016 and, until 2018, it operated under the Pharmznanie brand.

Since 2017, the company is included in the portfolio of one of the largest investment funds in Russia – the Internet Initiatives Development Fund. In two rounds of investments, the fund invested about $1.5 million in the company's projects.

In 2019, the company changed its brand to Pharma.Global for international business scaling and became a resident of the Skolkovo Innovation Centre. Today, Pharma.Global products are trendsetters in their field.


$17 billion
pharmaceutical companies
13,650 pharmacies
trust us to train their employees — 21% of the market
80,000 pharma specialists
use our products — 18% of the market
4,000 pharmacies
are connected to the PharmMarket platform
120 pharmaceutical companies
are in the partner list — 18% of the market
65,000 pharmacies
where you can use the Keshbek ot Aptek service — 100% of the market


Pharmznanie (the PharmaCourse brand in the global market) is a service for distance learning of pharma industry specialists. Online platform #1 in Russia in terms of share of pharmacy employees using the portal, as well as usability and interesting content.

Ipsos Comcon research data, Spring 2018 More

Rating of distance learning platforms by the share of pharmacists using them

Rating of distance learning platforms by usability

Rating of distance learning platforms by the interestingness of the materials offered

PharmMarket is a pharmaceutical marketplace that allows pharmaceutical companies to enter into direct contracts with pharmacies. The project makes the top 10 in total revenue and the top 5 in the number of pharmacies in the rating of pharmacy associations and pharmacy online projects.

data for 2018, RNC Pharma More

Keshbek ot Aptek (the PharmaBonus brand in the global market) is the first pharmaceutical cash-back program. For pharmaceutical companies, it is an opportunity to drive sales based on the CPA model and to obtain data about the consumer profile. For the buyer, it is an opportunity to significantly save on pharmaceutical products.